Literature DB >> 19309717

Congenital glioblastoma.

G M Milano1, C Cerri, V Ferruzzi, I Capolsini, E Mastrodicasa, L Genitori, F Aversa.   

Abstract

We describe the case a 2-day-old female with congenital glioblastoma. Total resection was followed by adjuvant and high dose chemotherapy, as indicated by the current Italian infant protocol. The child is alive and well 18 months after diagnosis. A review of 67 selected congenital brain tumors showed the mortality rate was 82%. Even though the majority of patients had glioblastoma, only 5/67 had received adjuvant therapy. To ensure optimal outcomes, we recommend total or subtotal surgical resection, followed by adjuvant and high dose chemotherapy. Given the lack specific protocols for congenital brain tumors an international consensus seems to be needed, starting with congenital glioblastoma. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19309717     DOI: 10.1002/pbc.22008

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Targetable molecular alterations in congenital glioblastoma.

Authors:  Ahmed Gilani; Andrew Donson; Kurtis D Davies; Susan L Whiteway; Jessica Lake; John DeSisto; Lindsey Hoffman; Nicholas K Foreman; B K Kleinschmidt-DeMasters; Adam L Green
Journal:  J Neurooncol       Date:  2019-12-24       Impact factor: 4.130

2.  Congenital tumors of the central nervous system.

Authors:  Mariasavina Severino; Erin S Schwartz; Majda M Thurnher; Jana Rydland; Ioannis Nikas; Andrea Rossi
Journal:  Neuroradiology       Date:  2010-04-29       Impact factor: 2.804

3.  Clinical and molecular characteristics of congenital glioblastoma.

Authors:  Margaret E Macy; Diane K Birks; Valerie N Barton; Michael H Chan; Andrew M Donson; B K Kleinschmidt-Demasters; Lynne T Bemis; Michael H Handler; Nicholas K Foreman
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

4.  Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology.

Authors:  Jason Fangusaro
Journal:  Front Oncol       Date:  2012-08-24       Impact factor: 6.244

Review 5.  Perinatal (fetal and neonatal) astrocytoma: a review.

Authors:  Hart Isaacs
Journal:  Childs Nerv Syst       Date:  2016-08-27       Impact factor: 1.475

6.  Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.

Authors:  Ludovica Facchini; Maurizio Lucchesi; Alessia Stival; Rosa Maria Roperto; Francesca Melosi; Marco Materassi; Silvia Farina; Veronica Tintori; Maurizio de Martino; Iacopo Sardi
Journal:  J Med Case Rep       Date:  2017-07-27

7.  A rare case of congenital glioblastoma with atypical presentation in an eleven month-old infant: Case report with review of literature.

Authors:  Vangala Bramha Prasad; Alugolu Rajesh; Aniruddh Kumar Purohit; Megha Shantveer Uppin
Journal:  Asian J Neurosurg       Date:  2017 Jan-Mar

8.  Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors.

Authors:  Milena Guidi; Laura Giunti; Anna Maria Buccoliero; Mariarita Santi; Barbara Spacca; Salvatore De Masi; Lorenzo Genitori; Iacopo Sardi
Journal:  Front Pediatr       Date:  2020-04-09       Impact factor: 3.418

9.  Clinical behaviour and outcome in pediatric glioblastoma: current scenario.

Authors:  Aditya Kumar Singla; Renu Madan; Kirti Gupta; Shikha Goyal; Narendra Kumar; Sushant Kumar Sahoo; Deepak K Uppal; Chirag K Ahuja
Journal:  Radiat Oncol J       Date:  2021-03-30

10.  A Case Report of a Rare Pediatric Brain Tumor: Congenital Glioblastoma.

Authors:  Antonio G Junior; Nina M P Abreu; Marcus Vinícius B Leal; Hilanne L A de Aquino; João Paulo C Rodrigues; Caio B Malveira; Yael P Silva; Pablo P A Coimbra
Journal:  Cureus       Date:  2022-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.